BYLASOL S.A. Supply Chain Due Diligence: Key Findings
Prepared by TradeMagellan Supply Chain Intelligence Desk
Supplier Dependency: Minimal Single-Point Risk
The due diligence profile for BYLASOL S.A. indicates a 0.00% dependency on any single supplier. This is a decisive positive signal from a supply chain resilience perspective. With no concentration risk concentrated in one vendor, an unexpected shutdown, quality failure, or contractual dispute at any individual supplier would not cripple BYLASOL’s procurement network.
Metric: Single-supplier dependency
Value: 0.00%
Risk interpretation: Low concentration risk — supply base appears well-diversified.
Because the dependency threshold is far below the 30% alert line, the company currently demonstrates structural resilience against single point of failure scenarios. This is a foundational strength, particularly in volatile global sourcing environments.
Relationship Assessment: Transactional During Trial Phase
While the supply base is broad, the nature of BYLASOL’s supplier relationships requires careful scrutiny. Two indicators stand out:
- Cooperation duration: Trial — indicates the relationship is still in an experimental or evaluation stage.
- Loyalty score: 1.00 — a low score that suggests minimal commitment, trust, or strategic alignment between BYLASOL and its suppliers.
These metrics strongly point toward a transactional relationship, rather than a strategic partnership. A strategic partnership typically involves multi-year agreements, joint planning, shared risk management, and high mutual loyalty. The trial phase combined with a low loyalty score implies that BYLASOL is likely sourcing on an order-by-order basis, with limited leverage, preferential pricing, or supply continuity guarantees.
Risk Implications and Recommendation
The combination of low supplier dependency and transactional, trial-stage relationships creates a nuanced risk picture:
- Resilience advantage: Low dependency reduces vulnerability to single-vendor disruptions.
- Continuity uncertainty: Trial-phase relationships can be terminated quickly, especially when loyalty is low. This may lead to supply gaps, price volatility, or inconsistent quality.
- Limited strategic leverage: A supplier with low loyalty has little incentive to prioritize BYLASOL during shortages or to offer favorable terms.
TradeMagellan assessment: BYLASOL S.A. has a solid structural buffer against supplier concentration risk. However, the low loyalty and trial status introduce operational fragility. The company should prioritize converting key trial suppliers into committed partners — through longer contracts, joint improvement programs, and supplier development initiatives — without sacrificing the diversification that currently protects it.
For now, the risk level attributable to supplier dependency is low, while the risk attributable to relationship depth is moderate to high if critical inputs rely on uncommitted vendors. TradeMagellan Supply Chain Intelligence will continue monitoring BYLASOL’s supplier portfolio dynamics.






























